Last SFr.86.55 CHF
Change Today -0.35 / -0.40%
Volume 8.1K
SANN On Other Exchanges
Symbol
Exchange
SANN is not on other exchanges.
As of 11:13 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - santhera pharmaceuticals-reg (SANN)

NameBoard RelationshipsTitleAge
Thomas Meier Ph.D.No RelationshipsChief Executive Officer52
Thomas Staffelbach No RelationshipsHead of Public & Investor Relations--

Board Members - santhera pharmaceuticals-reg (SANN)

NameBoard RelationshipsPrimary CompanyAge
Martin Gertsch CPA14 RelationshipsSanthera Pharmaceuticals Holding AG49
Klaus Schollmeier Ph.D.2 RelationshipsSuppreMol GmbH57
Jürg Ambühl 2 RelationshipsSanthera Pharmaceuticals Holding AG65

Executive Committees* - santhera pharmaceuticals-reg (SANN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMartin Gertsch CPA 14 Relationships2 Executives
View SANN Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SANN:SW SFr.86.55 CHF -0.35

SANN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SANN.
View Industry Companies
 

Industry Analysis

SANN

Industry Average

Valuation SANN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 355.1x
Price/Book 53.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 394.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANTHERA PHARMACEUTICALS-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.